UNSPSC 51282320: Erythromycin gluceptate

This classification denotes a macrolide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2AY21R0U64. European Medicines Agency schedules Erythromycin gluceptate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01943MIG. Erythromycin glucoheptonate generally arises in the molecular formula C37H67NO13.C7H14O8. The term 'erythromycin glucoheptonate' is a U.S. Pharmacopeial Convention designation.

UNSPSC 51282320 Erythromycin gluceptate is a Commodity code for a specific parenteral antibiotic formulation, but the recent state and local procurement activity under this code does not reflect purchases of erythromycin gluceptate itself. Instead, the code shows misalignment between its nominal scope and the work actually being solicited: the two recent opportunities tagged under this code involve pharmaceutical distribution logistics (a piggyback warehouse contract through a consortium purchasing vehicle) and naloxone plus drug deactivation systems procurement, neither of which matches the erythromycin gluceptate product classification. State and local buyers do use UNSPSC codes to tag pharmaceutical acquisitions, but the opportunities posted under this code suggest either tagging error or a broader use of this commodity code for general pharmaceutical supply chain activity beyond the specific drug named.

The Illinois Department of Public Health awarded a completed piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for $2,999,999.11 over three years (including renewal), covering Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through an Invitation for Bid process. Seminole County, Florida released an IFB in June 2026 for annual purchase of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, and a response deadline of July 26, 2023 (the date appears outdated in the record). Recent activity concentrates in Florida and Illinois, but the code shows minimal relevant recent solicitation volume — only two records, one a completed award and one with a stale deadline. Firms pursuing pharmaceutical supply under UNSPSC 51282320 should verify code alignment with specific product lines during opportunity review, as this code's recent posting history does not reliably reflect erythromycin gluceptate demand.